These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30170135)

  • 1. Towards the risk of yellow fever transmission in Europe.
    Javelle E; Gautret P; Raoult D
    Clin Microbiol Infect; 2019 Jan; 25(1):10-12. PubMed ID: 30170135
    [No Abstract]   [Full Text] [Related]  

  • 2. Yellow fever vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2003 Oct; 78(40):349-59. PubMed ID: 14569711
    [No Abstract]   [Full Text] [Related]  

  • 3. Is a dose of 17D vaccine in the current context of Yellow Fever enough?
    Estofolete CF; Nogueira ML
    Braz J Microbiol; 2018; 49(3):683-684. PubMed ID: 29588199
    [No Abstract]   [Full Text] [Related]  

  • 4. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
    Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
    Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recrudescence of yellow fever in Chad: case report of the last confirmed case in the health district of Lai-Chad].
    Djarma OM; Elisee D; Bolti MA; Sougoudi DA; Diop AB; Haggar FA; Hidjab A; Chatté A; Mad-Toingue J; Fissou H; Kolmian M; Moussa AM
    Pan Afr Med J; 2021; 38():248. PubMed ID: 34104296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yellow fever: a disease that has yet to be conquered.
    Barrett AD; Higgs S
    Annu Rev Entomol; 2007; 52():209-29. PubMed ID: 16913829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever vaccination centers: concurrent vaccinations and updates on mosquito biology.
    Arya SC; Agarwal N
    Travel Med Infect Dis; 2012 Sep; 10(5-6):257-8. PubMed ID: 22613468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional dosing of yellow fever vaccine during shortages: perspective from Canada.
    Teitelbaum P; Bui YG; Libman M; McCarthy A
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346564
    [No Abstract]   [Full Text] [Related]  

  • 11. Yellow Fever-More a Policy and Planning Problem than a Biological One.
    Calisher CH; Woodall JP
    Emerg Infect Dis; 2016 Oct; 22(10):1859-60. PubMed ID: 27479749
    [No Abstract]   [Full Text] [Related]  

  • 12. [Yellow fever--a tropical danger].
    Stingl P
    MMW Fortschr Med; 2004 Aug; 146(31-32):36-7. PubMed ID: 15529706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017.
    Dorigatti I; Hamlet A; Aguas R; Cattarino L; Cori A; Donnelly CA; Garske T; Imai N; Ferguson NM
    Euro Surveill; 2017 Jul; 22(28):. PubMed ID: 28749337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008.
    Johansson MA; Arana-Vizcarrondo N; Biggerstaff BJ; Gallagher N; Marano N; Staples JE
    Am J Trop Med Hyg; 2012 Feb; 86(2):349-58. PubMed ID: 22302873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neighbor danger: Yellow fever virus epizootics in urban and urban-rural transition areas of Minas Gerais state, during 2017-2018 yellow fever outbreaks in Brazil.
    Sacchetto L; Silva NIO; Rezende IM; Arruda MS; Costa TA; de Mello ÉM; Oliveira GFG; Alves PA; de Mendonça VE; Stumpp RGAV; Prado AIA; Paglia AP; Perini FA; Lacerda Nogueira M; Kroon EG; de Thoisy B; Trindade GS; Drumond BP
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008658. PubMed ID: 33017419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yellow fever resurgent.
    Mortimer PP
    Commun Dis Public Health; 2003 Jun; 6(2):85-6. PubMed ID: 12889284
    [No Abstract]   [Full Text] [Related]  

  • 17. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.
    Jentes ES; Han P; Gershman MD; Rao SR; LaRocque RC; Staples JE; Ryan ET; The Global TravEpiNet Consortium
    Am J Trop Med Hyg; 2013 May; 88(5):954-961. PubMed ID: 23458961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Staples JE; Gershman M; Fischer M;
    MMWR Recomm Rep; 2010 Jul; 59(RR-7):1-27. PubMed ID: 20671663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jan; 32(52):679-82, 687-8. PubMed ID: 6419048
    [No Abstract]   [Full Text] [Related]  

  • 20. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.